Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 2
2002 4
2003 2
2004 1
2017 1
2019 2
2020 2
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, Vendrely V, Artignan X, Bouché O, Gargot D, Boige V, Bonichon-Lamichhane N, Louvet C, Morand C, de la Fouchardière C, Lamfichekh N, Juzyna B, Jouffroy-Zeller C, Rullier E, Marchal F, Gourgou S, Castan F, Borg C; Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group. Conroy T, et al. Lancet Oncol. 2021 May;22(5):702-715. doi: 10.1016/S1470-2045(21)00079-6. Epub 2021 Apr 13. Lancet Oncol. 2021. PMID: 33862000 Clinical Trial.
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
Taïeb J, Bouche O, André T, Le Malicot K, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Perrier H, Buecher B, Di Fiore F, Gallois C, Emile JF, Lepage C, Elhajbi F, Tougeron D; SAMCO-PRODIGE 54 Investigators. Taïeb J, et al. Among authors: corbinais s. JAMA Oncol. 2023 Oct 1;9(10):1356-1363. doi: 10.1001/jamaoncol.2023.2761. JAMA Oncol. 2023. PMID: 37535388 Free PMC article.
A supportive care dedicated hospitalization ward in comprehensive cancer center.
Rambeau A, Renou M, Bisiaux F, Chaustier H, Joyaux C, Le Caer F, Fourel L, Solem-Laviec H, Poiree B, Corbinais S, Delorme C, Leloup-Morit V. Rambeau A, et al. Among authors: corbinais s. Support Care Cancer. 2020 Dec;28(12):5781-5785. doi: 10.1007/s00520-020-05421-0. Epub 2020 Mar 27. Support Care Cancer. 2020. PMID: 32219570
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
Dos Santos M, Lequesne J, Leconte A, Corbinais S, Parzy A, Guilloit JM, Varatharajah S, Brachet PE, Dorbeau M, Vaur D, Weiswald LB, Poulain L, Le Gallic C, Castera-Tellier M, Galais MP, Clarisse B. Dos Santos M, et al. Among authors: corbinais s. BMC Cancer. 2022 May 12;22(1):537. doi: 10.1186/s12885-022-09623-z. BMC Cancer. 2022. PMID: 35549674 Free PMC article. Clinical Trial.
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers.
Ollivier L, Guilloit JM, Dos Santos M, Guillemette L, Florescu C, M'vondo CM, Meyer E, Galais MP, Corbinais S, Parzy A, Varatharajah S, Lesueur P. Ollivier L, et al. Among authors: corbinais s. Int J Colorectal Dis. 2020 Mar;35(3):559-564. doi: 10.1007/s00384-019-03475-z. Epub 2019 Dec 18. Int J Colorectal Dis. 2020. PMID: 31853620
[Primary T-cell lymphoma of the common bile duct].
Corbinais S, Caulet-Maugendre S, Pagenault M, Spiliopoulos Y, Dauriac C, Mendler MH. Corbinais S, et al. Gastroenterol Clin Biol. 2000 Aug-Sep;24(8-9):843-7. Gastroenterol Clin Biol. 2000. PMID: 11011261 Free article. French.
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.
Bourgeois H, Grudé F, Solal-Céligny P, Dupuis O, Voog E, Ganem G, Denis F, Zinger M, Juhel-Voog L, Lafond C, Maillart P, Capitain O, Delva R, Soulié P, Abadie-Lacourtoisie S, Guérin-Meyer V, Morin-Meschin ME, Commer JM, Gangler A, d'Aillières B, Zannetti A, Bourbouloux E, Berton-Rigault D, Lebouvier-Sadot S, Kaassis M, Baudon J, Lam YH, Bizieux A, Marcq M, Edeline J, Le Du F, Lefeuvre C, Deguiral P, Delecroix V, Blot E, Egreteau J, Goudier MJ, Lamy R, Ferec M, Artignan X, Corbinais S, Morel H, Hardy-Bessard AC, Alleaume C, Naudeix E, Cojocarasu O, Metges JP, Riché C, Gamelin E, Déniel-Lagadec D, Marhuenda F, Ingrand P, Douillard JY. Bourgeois H, et al. Among authors: corbinais s. Ann Oncol. 2017 Jul 1;28(7):1612-1617. doi: 10.1093/annonc/mdx172. Ann Oncol. 2017. PMID: 28472235 Free article.
[Comment on case report: A difficult mourning period].
Siproudhis L, Corbinais S, Bicheler V. Siproudhis L, et al. Among authors: corbinais s. Gastroenterol Clin Biol. 2001 Nov;25(11):989-91. Gastroenterol Clin Biol. 2001. PMID: 11845050 Free article. French. No abstract available.
19 results